Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration

Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration

All-trans-retinoic acid (ATRA) is the standard of care for the management of acute promyelocytic leukemia (APL), but can be associated with differentiation syndrome (DS). Over a seven-year period, we sought to determine the impact of ATRA initiation time on the development of DS. ATRA administration...

Full description

Bibliographic Details
Main Authors: Mary Nauffal, Lillian Werner, Jian Ni, Richard M. Stone, Daniel J. DeAngelo, Anne M. McDonnell
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Leukemia Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048919300524

Internet

http://www.sciencedirect.com/science/article/pii/S2213048919300524

Similar Items